Determining the Minimal Clinical Important Difference for Medication Quantification Scale III and Morphine Milligram Equivalents in Patients with Failed Back Surgery Syndrome
Open Access
- 21 November 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (11) , 3747
Abstract
The Medication Quantification Scale III (MQS) is a tool to represent the negative impact of medication. A reduction in medication can serve as an indicator to evaluate treatment success. However, no cut-off value has yet been determined to evaluate whether a decrease in medication is clinically relevant. Therefore, the objective is to estimate the thresholds for the MQS and morphine milligram equivalents (MMEs) that best identify a clinically relevant important improvement for patients. Data from the Discover registry, in which patients with failed back surgery syndrome were treated with high-dose spinal cord stimulation, were used. Patient satisfaction was utilized to evaluate a clinically important outcome 12 months after stimulation. Anchor-based and distribution-based methods were applied to determine the minimal clinical important difference (MCID). Distribution-based methods revealed a value of 4.28 for the MQS and 33.61 for the MME as MCID. Anchor-based methods indicated a percentage change score of 41.2% for the MQS and 28.2% for the MME or an absolute change score of 4.72 for the MQS and 22.65 for the MME. For assessing a treatment outcome, we recommend using the percentage change score, which better reflects a clinically important outcome and is not severely influenced by high medication intake at baseline.Keywords
Funding Information
- Medtronic Europe SARL (independent research grant)
This publication has 33 references indexed in Scilit:
- Different minimally important clinical difference (MCID) scores lead to different clinical prediction rules for the Oswestry disability index for the same sample of patientsJournal of Manual & Manipulative Therapy, 2013
- Clinimetrics corner: a closer look at the minimal clinically important difference (MCID)Journal of Manual & Manipulative Therapy, 2012
- Medication Quantification Scale Version III: Internal Validation of Detriment Weights Using a Chronic Pain PopulationPain Practice, 2008
- Understanding the minimum clinically important difference: a review of concepts and methodsThe Spine Journal, 2007
- Medication Quantification Scale Version III: Update in Medication Classes and Revised Detriment Weights by Survey of American Pain Society PhysiciansThe Journal of Pain, 2005
- Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scaleEuropean journal of pain, 2004
- Interpretation of Changes in Health-related Quality of LifeMedical Care, 2003
- Determining Clinically Important Differences in Health Status MeasuresPharmacoEconomics, 1999
- Chronic-Pain MedicationsThe Clinical Journal of Pain, 1992
- Measurement of health statusControlled Clinical Trials, 1989